Evaluation of blood cell count using an automatic hematology analyzer to optimize collection of peripheral blood progenitor cells by leukapheresis.

Apheresis CD34(+) enumeration Good mobilizers PBSC collection Stem cell transplantation

Journal

Hematology, transfusion and cell therapy
ISSN: 2531-1387
Titre abrégé: Hematol Transfus Cell Ther
Pays: Brazil
ID NLM: 101725732

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 11 11 2022
revised: 01 03 2024
accepted: 01 04 2024
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

Autologous stem cell transplantation is a treatment modality for several diseases. Prediction of successful mobilization may be useful to optimize hematopoietic stem cell collection. This was a retrospective study with data from transplantation candidates between September 2015 and December 2021 being analyzed. The medical record of each patient was reviewed to mine mobilization information. The laboratory data analyzed were CD34 This study included 807 patients. Increased patient weight, low mean corpuscular volume, high nucleated red blood cells, peripheral blood mononuclear cell and immature granulocyte counts were significantly associated with good mobilization. In addition, patients diagnosed with multiple myeloma were two times more likely to be good mobilizers than patients with lymphoma. The model was applied to a validation set to identify patients who underwent apheresis (CD34 Success in mobilization was greater in patients who underwent the first mobilization cycle and who had a diagnosis of multiple myeloma. Furthermore, higher body weight, and nucleated red blood cells, immature granulocytes and mononuclear cell counts, as well as low mean corpuscular volumes, were associated with successful mobilization.

Sections du résumé

BACKGROUND BACKGROUND
Autologous stem cell transplantation is a treatment modality for several diseases. Prediction of successful mobilization may be useful to optimize hematopoietic stem cell collection.
STUDY DESIGN AND METHODS METHODS
This was a retrospective study with data from transplantation candidates between September 2015 and December 2021 being analyzed. The medical record of each patient was reviewed to mine mobilization information. The laboratory data analyzed were CD34
RESULTS RESULTS
This study included 807 patients. Increased patient weight, low mean corpuscular volume, high nucleated red blood cells, peripheral blood mononuclear cell and immature granulocyte counts were significantly associated with good mobilization. In addition, patients diagnosed with multiple myeloma were two times more likely to be good mobilizers than patients with lymphoma. The model was applied to a validation set to identify patients who underwent apheresis (CD34
CONCLUSION CONCLUSIONS
Success in mobilization was greater in patients who underwent the first mobilization cycle and who had a diagnosis of multiple myeloma. Furthermore, higher body weight, and nucleated red blood cells, immature granulocytes and mononuclear cell counts, as well as low mean corpuscular volumes, were associated with successful mobilization.

Identifiants

pubmed: 38719718
pii: S2531-1379(24)00219-0
doi: 10.1016/j.htct.2024.04.117
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The authors have no conflict of interest to declare

Auteurs

Paula Renata Machado Passos Pederzoli (PRMP)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Karen de Lima Prata (KL)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Nathália Gomide Cruz (NG)

Fundação Hemominas, Alameda Ezequiel Dias, 321, Belo Horizonte, Minas Gerais 30130-110, Brazil.

Pedro Victorio de Almeida Marzano (PVA)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Maurício Colombini Martins (MC)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Luciana de Almeida Costa (LA)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Roberta Kelly de Andrade (RK)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil.

Marcia Regina Issa Salomão Libânio (MRIS)

Secretaria de Estado da Saúde de Minas Gerais, Cidade Administrativa, Edifício Minas, 12º andar, Rod. Papa João Paulo II - Serra Verde, Belo Horizonte, Minas Gerais 31585-200, Brazil.

Brian Custer (B)

Vitalant Research Institute, 360 Spear St Suite 200, San Francisco, CA 94105, USA; Department of Laboratory Medicine, UCSF. 185 Berry Street, Suite 100, Box 0134, San Francisco, CA 94143-0134, USA.

André Rolim Belisário (AR)

Centro de Tecidos Biológicos de Minas Gerais, Fundação Hemominas, Rua das Goiabeiras, 779, Lagoa Santa, Minas Gerais 33400-000, Brazil. Electronic address: andre.belisario@hemominas.mg.gov.br.

Classifications MeSH